- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 89Zr-DFO-HuMab-5B1 (MVT-2163)
Total 219 results
-
BioNTech Research & Development, Inc.SciQuus OncologyTerminatedPancreatic Carcinoma | Tumors That Express CA19-9United States
-
Memorial Sloan Kettering Cancer CenterBioNTech SEActive, not recruitingPancreatic Cancer | Tumors That Express CA19-9United States
-
BioNTech Research & Development, Inc.TerminatedPancreatic Carcinoma | Tumors That Express CA 19-9United States
-
Memorial Sloan Kettering Cancer CenterRecruitingPancreatic CystUnited States
-
National Cancer Institute (NCI)CompletedPancreatic Cancer | Cholangiocarcinoma | Colon Cancer | Liver Metastasis | Metastatic Colon CarcinomaUnited States
-
Telix Pharmaceuticals (Innovations) Pty LimitedCompletedClear Cell Renal Cell CarcinomaUnited Kingdom, United States, Australia, Turkey, Netherlands, Belgium, Canada, France
-
Telix International Pty LtdCompletedCarcinoma, Renal Cell | Clear Cell Renal Cell CarcinomaJapan
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Completed
-
Telix International Pty LtdGrand Pharmaceutical (China) Co., Ltd.CompletedClear Cell Renal Cell Carcinoma | Recurrent Renal Cell Cancer | Suspected Recurrent Renal Clear Cell CarcinomaChina
-
Telix International Pty LtdRecruitingSoft Tissue Sarcoma | Cervical Cancer | Nasopharyngeal Carcinoma | Small Cell Lung Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | Esophageal Cancer | Glioblastoma Multiforme | Non Small Cell Lung Cancer | Cholangiocarcinoma | Epithelial Ovarian Cancer | Head and Neck Squamous Cell Carcinoma and other conditionsUnited States
-
Université de SherbrookeEli Lilly and Company; Chorus Wellness Inc.; AL-S Pharma AGRecruitingAmyotrophic Lateral SclerosisCanada
-
Telix Pharmaceuticals (Innovations) Pty LimitedAvailable
-
BioNTech Research & Development, Inc.RecruitingPancreatic CancerUnited States
-
Robert Flavell, MD, PhDSuspended
-
Monopar TherapeuticsRecruitingGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Bladder Cancer | Urothelial Carcinoma | Triple-negative Breast Cancer | Solid Tumor, AdultAustralia
-
University of SaskatchewanRecruitingColorectal Cancer | Lung CancerCanada
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingDLBCL | Large B-cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell University; Broad InstituteCompleted
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingPituitary Adenoma | Brain CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedEsophagogastric CancerUnited States
-
Aplagon OyTRACER Europe BVRecruitingPeripheral Arterial Occlusive Disease | Critical Limb IschemiaNetherlands
-
Memorial Sloan Kettering Cancer CenterWithdrawn
-
Amsterdam UMC, location VUmcAstraZenecaRecruitingBreast Cancer | Gastric Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric CancerNetherlands
-
Memorial Sloan Kettering Cancer CenterRecruitingSmall Cell Lung Carcinoma | Small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedMultiple MyelomaUnited States
-
Telix Pharmaceuticals (Innovations) Pty LimitedMerck KGaA, Darmstadt, GermanyRecruitingAdvanced Solid Tumor | Solid Tumor, Adult | Advanced Renal Cell CarcinomaAustralia
-
University Medical Center GroningenRegeneron PharmaceuticalsActive, not recruiting
-
Robert Flavell, MD, PhDUnited States Department of Defense; Fortis Therapeutics, Inc.RecruitingProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Robert Flavell, MD, PhDNational Cancer Institute (NCI)RecruitingMultiple Myeloma | Plasma Cell MyelomaUnited States
-
James BrugarolasRecruitingRenal Cell CarcinomaUnited States
-
Regeneron PharmaceuticalsRecruitingAdvanced Solid Tumor | Metastatic Solid TumorNetherlands
-
Microvascular Therapeutics, LLCNational Heart, Lung, and Blood Institute (NHLBI); University of NebraskaRecruitingHeart DiseasesUnited States
-
University of California, San FranciscoamfAR, The Foundation for AIDS ResearchRecruitingHIV-1-infectionUnited States
-
New York Institute of TechnologyTerminatedSedentary Behavior | Compression; Vein | Compression; Artery | DVT of LegsUnited States
-
Boehringer IngelheimRecruitingMelanoma | Non-small Cell Lung Cancer (NSCLC) | Carcinoma, Squamous Cell of Head and Neck (HNSCC)Netherlands
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
Genentech, Inc.Completed
-
Memorial Sloan Kettering Cancer CenterUnited States Department of Defense; Genentech, Inc.CompletedBreast Cancer Metastases | HER2 Positive BreastUnited States
-
University Medical Center GroningenActive, not recruitingLocally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 ExpressionNetherlands
-
Affiliated Hospital of Jiangnan UniversityRecruiting
-
Wuxi No. 4 People's HospitalNot yet recruitingSolid Tumor, AdultChina
-
Wuxi No. 4 People's HospitalUnknownSolid Tumor, AdultChina
-
South Metropolitan Health ServiceTelix Pharmaceuticals (Innovations) Pty LimitedCompletedUrothelial CarcinomaAustralia
-
Radboud University Medical CenterABX CRO; Telix International Pty LtdCompleted
-
University of Alabama at BirminghamRecruiting
-
Affiliated Hospital of Jiangnan UniversityRecruiting
-
Sinotau Pharmaceutical GroupNot yet recruiting
-
Memorial Sloan Kettering Cancer CenterWeill Medical College of Cornell UniversityCompleted
-
ImaginAb, Inc.RecruitingMelanoma | Renal Cell Carcinoma | Non Small Cell Lung Cancer | Merkel Cell Carcinoma, UnspecifiedUnited States, Australia, Belgium, Netherlands, Switzerland, United Kingdom
-
Memorial Sloan Kettering Cancer CenterCompletedHER2-positive Carcinoma | HER2-positive Primary MalignancyUnited States